Jiangsu Synthgene Biotechnology

Established in 2018, Jiangsu Synthgene Biotechnology Co., Ltd. is an advanced enterprise engaged in the research and development of technology and products related to fundamental raw materials including nucleosides, nucleotides, diagnostic antigens, and antibodies. With a focus on delivering cost-efficient products and addressing unmet clinical requirements, the company has ventured into the upstream foundational raw materials sector of IVD, mRNA, CGT, and other industries. Additionally, it has set up a high-quality fundamental technology platform to offer comprehensive solutions for advancements in the life sciences sector.